Supplementary Figures 1-8 from Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Thomas Enzler; Yasuyo Sano; Min‐Kyung Choo; Howard B. Cottam; Michael Karin; Hensin Tsao; Jin Mo Park

doi:10.1158/2159-8290.22528710

Back

Supplementary Figures 1-8 from Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Preprint 2023 en

Discussion(0)

No comments yet. Be the first to comment.

Open reviews(0)

Public, signed peer feedback on this preprint.

No reviews yet.

Related publications

Preprint2023

Supplementary Figures 1-8 from Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Thomas Enzler, Yasuyo Sano, Min‐Kyung Choo, Howard B. Cottam, Michael Karin, Hensin Tsao, Jin Mo Park

Preprint2023

Data from Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Thomas Enzler, Yasuyo Sano, Min‐Kyung Choo, Howard B. Cottam, Michael Karin, Hensin Tsao, Jin Mo Park

Preprint2023

Data from Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Thomas Enzler, Yasuyo Sano, Min‐Kyung Choo, Howard B. Cottam, Michael Karin, Hensin Tsao, Jin Mo Park

Article2011

Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Thomas Enzler, Yasuyo Sano, Min‐Kyung Choo, Howard B. Cottam, Michael Karin, Hensin Tsao, Jin Mo Park

Preprint2023

Supplementary Figure 1 from Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma

James S. Wilmott, Georgina V. Long, Julie R. Howle, Lauren E. Haydu, Raghwa Sharma, John F. Thompson, Richard F. Kefford, Peter Hersey, Richard A Scolyer

Supplementary Figures 1-8 from Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Abstract

Discussion(0)

Open reviews(0)

Related publications

Supplementary Figures 1-8 from Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Data from Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Data from Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Cell-Selective Inhibition of NF-κB Signaling Improves Therapeutic Index in a Melanoma Chemotherapy Model

Supplementary Figure 1 from Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma